Avista Capital Partners will acquire Miraca Life Sciences from Miraca Holdings, according to a news release.
Miraca Life Sciences, based in Irving, Texas, is a national, independent anatomic pathology lab providing subspecialty anatomic pathology services in the fields of gastroenterology, dermatology, hematology, breast health and urology.
Avista, headquartered in New York, a private equity firm that makes middle-market control buyout investments in the healthcare sector. Founded in 2005, the company has approximately $6 billion under management.
Miraca Holdings is a Japan-based holding company in the healthcare sector.
Financial terms were not disclosed.
